ZIVO Bioscience, Inc.
Index- P/E- EPS (ttm)-1.06 Insider Own8.60% Shs Outstand9.42M Perf Week-2.89%
Market Cap26.20M Forward P/E- EPS next Y-0.83 Insider Trans14.81% Shs Float6.25M Perf Month-14.60%
Income-9.00M PEG- EPS next Q-0.22 Inst Own5.00% Short Float1.73% Perf Quarter-22.03%
Sales- P/S- EPS this Y33.00% Inst Trans-9.65% Short Ratio8.38 Perf Half Y-18.24%
Book/sh0.49 P/B5.49 EPS next Y27.20% ROA-92.60% Target Price9.00 Perf Year-73.93%
Cash/sh0.68 P/C3.97 EPS next 5Y- ROE-139.50% 52W Range2.37 - 10.40 Perf YTD-6.27%
Dividend- P/FCF- EPS past 5Y19.80% ROI- 52W High-74.13% Beta0.20
Dividend %- Quick Ratio2.50 Sales past 5Y- Gross Margin- 52W Low13.60% ATR0.19
Employees10 Current Ratio2.50 Sales Q/Q- Oper. Margin- RSI (14)33.44 Volatility6.94% 6.29%
OptionableNo Debt/Eq0.17 EPS Q/Q49.50% Profit Margin- Rel Volume0.10 Prev Close2.61
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume12.92K Price2.69
Recom2.00 SMA20-12.15% SMA50-21.75% SMA200-21.20% Volume1,229 Change3.06%
Apr-25-22 04:05PM  
Jan-10-22 05:00PM  
Oct-06-21 10:10AM  
Oct-05-21 12:57PM  
Sep-24-21 11:35AM  
Aug-17-21 04:05PM  
Aug-16-21 08:30AM  
Aug-11-21 08:00AM  
Jul-02-21 08:00AM  
Jun-02-21 09:30AM  
May-27-21 08:42PM  
Apr-26-21 12:06PM  
Mar-11-21 12:25PM  
Jan-11-21 02:50PM  
Jan-07-21 04:35PM  
Jul-13-20 08:00AM  
Jun-09-20 08:30AM  
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is based in Keego Harbor, Michigan.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Maggiore Christopher D.DirectorFeb 11Buy3.8744,965173,952803,105Feb 16 06:02 AM
Maggiore Christopher D.DirectorFeb 10Buy3.6318,00665,452758,140Feb 16 06:02 AM
Maggiore Christopher D.DirectorFeb 09Buy3.5528,363100,694740,134Feb 16 06:02 AM
PAYNE JOHN BERNARDDirectorJan 27Buy2.50461159,344Jan 28 05:39 PM
PAYNE JOHN BERNARDDirectorJan 25Buy2.509,12222,8059,298Jan 28 05:39 PM
Maggiore Christopher D.DirectorJan 11Buy2.647,56019,956711,771Jan 14 05:48 PM
Masterson Nola EDirectorJun 02Buy4.994001,9964,898Jun 04 03:53 PM
Cornell Alison ADirectorJun 02Buy4.9915,00074,85015,000Jun 04 03:49 PM
Maggiore Christopher D.DirectorJun 02Buy4.99100,000499,000704,211Jun 04 03:44 PM